NOV 28, 2015 6:44 AM PST

Rare Tropical Disease Puts Transplant Patients At Risk

WRITTEN BY: Kara Marker
Leishmaniasis is an infectious disease caused by the bite of parasite-infected sand flies, and it's usually found in tropical regions and southern Europe. The infection can be either cutaneous, causing skin sores, or visceral, affecting internal organs (CDC). The number of leishmaniasis infections has quadrupled since the 1990s, and researchers from Spain looked to calculate the risk and determine how to prevent infections in vulnerable transplant patients. 
 Geographical distribution of visceral leishmaniasis

In a recent study published in PLoS Neglected Tropical Diseases, scientists looked at 63 individuals who had received solid organ transplants and worked to determine the number of patients who had come into contact with the parasite and what their risk was of developing leishmaniasis at any point for the rest of their lives. Because of the immunosuppressive therapy transplant patients receive to prevent organ rejection, these patients have a 100 times greater risk of developing severe visceral leishmaniasis compared to immunocompetent people.

The team conducted two tests scanning for any form of leishmaniasis infection. One test involved experimental lymphocyte proliferation assays and cytokine production analysis, to examine how the immune system was working, potentially hinting at a leishmaniasis invasion. The second test was more routine - "serologic and parasitology tests" that are normally used to diagnose cases of leishmaniasis. 

The scientists saw a correlation between the two tests, and this initial success points to the experimental assays as new indicators of leishmaniasis progression at various stages of infection. Continuing studies with these analytic tests could help scientists understand the relationship between transplant patients and their lifetime risk of developing leishmaniasis. 

Ultimately, the team is interested in preventing the initial transmission of leishmaniasis as well as relapse recovery. Identifying which immunocompromised patients are at high risk of relapsing with infection could help doctors know when to administer additional chemotherapeutics to prevent additional infections in individuals not completely recovered. 

"Being the recipient of an organ tranplant is increasingly common amoung the Spanish population," said Dr. Javier Moreno, team researcher. "As a consequence, it is necessary to both prevent the risk of infection in transplant patients and to adopt appropriate measures for disease management and prevention in clinical cases in order to prevent relapses."

Watch the following video to learn more about leishmaniasis. 

Source: Plataforma SINC
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 25, 2019
Immunology
SEP 25, 2019
Your Immune Response Varies from AM to PM
“My biological clock is ticking.” We’ve heard people say this phrase - maybe even said it ourselves - but what do we mean exactly? Often...
SEP 29, 2019
Drug Discovery & Development
SEP 29, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
DEC 20, 2019
Neuroscience
DEC 20, 2019
Does Having Herpes Increase Your Risk for Alzheimer's?
Around 44 million people around the world have Alzheimer’s disease, a progressive form of dementia that leads to memory loss and a decline in cogniti...
JAN 07, 2020
Immunology
JAN 07, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
FEB 01, 2020
Cell & Molecular Biology
FEB 01, 2020
Immunity in the Gut Ramps Up Around Mealtimes
Scientists have found that our immune system benefits when we eat regular meals....
Loading Comments...